SAGE Insider Trading Activity and SEC Form 4 Filings
SAGE insider trading summary
No open-market insider purchases or sales of Sage Therapeutics, Inc. (SAGE) have been reported on SEC Form 4 in the past 12 months.
Latest SAGE insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 9, 2023 | Elizabeth Barrett | Insider | Buy | $37K (2,000 @ $18.64) |
| May 9, 2023 | Elizabeth Barrett | Insider | Buy | $51K (1,000 @ $50.50) |
| Feb 10, 2023 | Jeffrey M Jonas | Insider | Sell | $347K (7,805 @ $44.47) |
| Feb 10, 2023 | Jeffrey M Jonas | Insider | Sell | $172K (3,838 @ $44.90) |
| Nov 10, 2022 | Barry E Greene | President and CEO | Buy | $500K (14,500 @ $34.48) |
| May 5, 2022 | George Golumbeski | Insider | Buy | $252K (8,000 @ $31.45) |
| Aug 5, 2021 | Barry E Greene | President and CEO | Buy | $1.0M (23,640 @ $43.15) |
| Jun 16, 2021 | Kevin P Starr | Insider | Buy | $1000K (17,842 @ $56.05) |
| Jun 16, 2021 | Barry E Greene | President and CEO | Buy | $496K (8,800 @ $56.32) |
| Jun 16, 2021 | James M Frates | Insider | Buy | $100K (1,810 @ $55.10) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.